AMED - Amedisys, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
4.8B
Enterprise Value 3
5.12B
Trailing P/E
39.16
Forward P/E 1
31.46
PEG Ratio (5 yr expected) 1
2.05
Price/Sales (ttm)
2.54
Price/Book (mrq)
8.07
Enterprise Value/Revenue 3
2.71
Enterprise Value/EBITDA 6
27.20

Trading Information

Stock Price History

Beta (3Y Monthly) 1.37
52-Week Change 327.32%
S&P500 52-Week Change 313.46%
52 Week High 3154.14
52 Week Low 3103.76
50-Day Moving Average 3133.51
200-Day Moving Average 3126.48

Share Statistics

Avg Vol (3 month) 3259.05k
Avg Vol (10 day) 3419.75k
Shares Outstanding 532.26M
Float 31.92M
% Held by Insiders 11.16%
% Held by Institutions 192.98%
Shares Short (Oct 15, 2019) 41.68M
Short Ratio (Oct 15, 2019) 46.25
Short % of Float (Oct 15, 2019) 47.34%
Short % of Shares Outstanding (Oct 15, 2019) 45.22%
Shares Short (prior month Sep 13, 2019) 41.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/4
Last Split Date 3Dec 5, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 6.70%
Operating Margin (ttm)9.12%

Management Effectiveness

Return on Assets (ttm)11.11%
Return on Equity (ttm)24.34%

Income Statement

Revenue (ttm)1.89B
Revenue Per Share (ttm)58.94
Quarterly Revenue Growth (yoy)18.50%
Gross Profit (ttm)669.72M
EBITDA 188.16M
Net Income Avi to Common (ttm)126.64M
Diluted EPS (ttm)3.85
Quarterly Earnings Growth (yoy)8.80%

Balance Sheet

Total Cash (mrq)20.76M
Total Cash Per Share (mrq)0.64
Total Debt (mrq)324M
Total Debt/Equity (mrq)53.69
Current Ratio (mrq)0.95
Book Value Per Share (mrq)18.69

Cash Flow Statement

Operating Cash Flow (ttm)190.81M
Levered Free Cash Flow (ttm)169.07M